Ruoxi Chen
Mr. Ruoxi Chen is an Independent Director at Sotera Health Co. and a Managing Director at Warburg Pincus LLC. He is on the Board of Directors at Sotera Health Co., Accriva Diagnostics, Inc., ComplexCare Solutions, Inc., Singular Bio, Inc., Vertice Pharma UK Finance Ltd., Vertice Pharma UK Holdings Ltd., Vertice Pharma UK Intermediate Ltd., Vertice Pharma UK Parent Ltd. and Vertice Pharma UK Parent Ltd. (United Kingdom).
Mr. Chen was previously employed as an Independent Director by Silk Road Medical, Inc. and an Associate by The Carlyle Group, Inc. /Old/. He also served on the board at Melinta Subsidiary Corp.
He received his undergraduate degree from Duke University and an MBA from Harvard Business School.
Transactions
Date
Transaction
Value
| 05/26/2023 | 15,712 | Award at $0 per share. | 0 |
| 05/27/2022 | 10,643 | Award at $0 per share. | 0 |
| 05/28/2021 | 9,336 | Award at $0 per share. | 0 |
| 11/20/2020 | 5,869 | Award at $0 per share. | 0 |
